YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[View of Moderna office entrance with logo sign, Biotechnology industry] Veronique D Shares of Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) have rallied 202% since Aug. 18, fueled by positive news about the biotech company's exper…
Biotech firms have been increasingly directing capital toward oncology therapeutics in recent years, reflecting a structural shift as companies recognize the significant commercial potential of precision oncology. According to BioPharma Di…
Fidelity MSCI Health Care Index ETF (NYSEMKT:FHLC) offers broad healthcare exposure at a fraction of the cost, while First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides an aggressive, concentrated focus on biotechnology i…
The biotechnology industry has been mounting a powerful rally, emerging as a standout performer in the equity market, which has otherwise been dominated by technology giants of late. Over the past year, the industry's resurgence has been f…
[US 100 dollar bill folded into an up arrow on wooden table. Illustration of the concept of inflation, profit, earning and investment] Biotech stocks have reached their highest level since the height of the pandemic after Moderna (MRNA [ht…
The State Street SPDR S&P Biotech ETF (NYSEMKT:XBI) provides broad exposure to the biotech industry, while the First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) offers a much more concentrated, equal-weighted alternative. Biotec…
Determining whether State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) or First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) fits a portfolio depends on an investor's preference for broad-sector stability or concentrat…
Key Points State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to the 0.55% charged by First Trust NYSE Arca Biotechnology Index Fund. First Trust's fund focuses exclusively on 30 bi…
Quick Read FBT's equal-weight design beat IBB by 35 percentage points over five years, returning 47% versus IBB's 13% despite carrying a higher expense ratio. IBB puts nearly 30% into four mega-caps (Vertex, Amgen, Gilead, and Regeneron),…
Key Points Vanguard Health Care ETF is significantly more affordable than First Trust NYSE Arca Biotechnology Index Fund while offering much broader exposure across the healthcare sector. First Trust NYSE Arca Biotechnology Index Fund has…
The First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides concentrated, high-conviction exposure to biotechnology firms, while the Vanguard Health Care ETF (NYSEMKT:VHT) offers a cheaper, diversified basket across the entir…
iShares Global Healthcare ETF (NYSEMKT:IXJ) offers broad diversification across global healthcare sectors at a lower cost, while First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) provides a concentrated bet on biotechnology. Hea…
Key Points iShares Global Healthcare ETF provides broad exposure to 110 global stocks while First Trust NYSE Arca Biotechnology Index Fund concentrates on 30 biotech positions. iShares Global Healthcare ETF carries a lower expense ratio of…
Investors choosing between the State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) and First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) must weigh XLV's broad healthcare diversification and low cost against FBT's conc…
The weight-loss boom has created one of the market's biggest opportunities — and some of its most punishing failures. A single clinical result can send a stock soaring, wipe out years of gains, or threaten the company itself. Drug developm…
Key Points First Trust NYSE Arca Biotechnology Index Fund offers a more concentrated portfolio with only 30 holdings compared to the 248 positions in iShares Biotechnology ETF iShares Biotechnology ETF is the larger and more established fu…
Comparing First Trust NYSE Arca Biotechnology Index Fund (NYSEMKT:FBT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between FBT's highly concentrated portfolio and IBB's broader, market-cap-weighted industry exposure. Both f…
[Bubble] Petrovich9 The top 10 stocks in the U.S. now represent approximately 45% of total market capitalization, a level of concentration that has broken traditional market trend lines and left investors struggling to determine whether th…
The State Street SPDR S&P Pharmaceuticals ETF(NYSEMKT:XPH) offers a lower-cost entry into the drug manufacturing space, while the First Trust NYSE Arca Biotechnology Index Fund(NYSEMKT:FBT) provides concentrated exposure to biotechnology.…
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund launched on February 5, 2001. An increasingly popular option among…
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the First Trust NYSE Arca Biotechnology Index Fund (Symbol: FBT) where we have detected an approximate $153.8 mil…
Top 10 Creations (All ETFs) Ticker Name Net Flows ($, mm) AUM ($, mm) AUM % Change GLD SPDR Gold Shares 1,066.13 168,759.56 0.63% ARKK ARK Innovation ETF 1,023.28 8,584.85 11.92% VOO Vanguard S&P 500 ETF 911.06 861,115.91 0.11% FBT First T…
Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. Passively managed ETFs are becomin…
[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Eli Lilly (LLY [https://seekingalpha.com/symbol/LLY]) officially joined the elite group of U.S. companies valued at more than $1T on Friday, becoming the tenth American…
Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to date, IBB has risen 23.6% versus SPY’s…
Denver, Colorado , Oct. 15, 2025 (GLOBE NEWSWIRE) -- Future BookSea Technology Ltd. (FBT), a global leader in digital reading and cultural innovation, today announced the official launch of its Global Reading Initiative, a program designed…
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on February 5, 2001. Retail and institutional i…
In trading on Wednesday, the First Trust NYSE Arca Biotechnology Index Fund ETF is outperforming other ETFs, up about 3.7% on the day. Components of that ETF showing particular strength include shares of Moderna, up about 8.8% and shares o…
FORESIGHT VENTURES VCT PLC LEI: 213800R88MRC4Y3OIW86 29 July 2025 Final results 31 March 2025 Foresight Ventures VCT plc, managed by Foresight Group LLP, today announces the final results for the year ended 31 March 2025. These results wer…
In trading on Thursday, shares of the First Trust NYSE Arca Biotechnology Index Fund ETF (Symbol: FBT) crossed above their 200 day moving average of $167.91, changing hands as high as $169.60 per share. First Trust NYSE Arca Biotechnology…
In this article, we discuss the 10 best performing biotech ETFs in 2024. If you want to skip our detailed introduction to the biotech industry and just want to take a look at some more ETFs, go directly to the 5 Best Performing Biotech ETF…
In this article, we discuss 11 best biotech ETFs to buy. If you want to skip our discussion on the biotech industry, head over to 5 Best Biotech ETFs To Buy. The new era in biotech is defined by the convergence of biology, data, and artifi…